JP2020523029A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523029A5 JP2020523029A5 JP2019569397A JP2019569397A JP2020523029A5 JP 2020523029 A5 JP2020523029 A5 JP 2020523029A5 JP 2019569397 A JP2019569397 A JP 2019569397A JP 2019569397 A JP2019569397 A JP 2019569397A JP 2020523029 A5 JP2020523029 A5 JP 2020523029A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- cancer
- hue71
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520382P | 2017-06-15 | 2017-06-15 | |
| US62/520,382 | 2017-06-15 | ||
| PCT/US2018/037645 WO2018232188A1 (en) | 2017-06-15 | 2018-06-14 | Anti-l1-cam antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523029A JP2020523029A (ja) | 2020-08-06 |
| JP2020523029A5 true JP2020523029A5 (enExample) | 2021-07-26 |
| JP7353187B2 JP7353187B2 (ja) | 2023-10-05 |
Family
ID=64660699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569397A Active JP7353187B2 (ja) | 2017-06-15 | 2018-06-14 | 抗ｌ１－ｃａｍ抗体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11597764B2 (enExample) |
| EP (1) | EP3638299A4 (enExample) |
| JP (1) | JP7353187B2 (enExample) |
| CN (2) | CN119161477A (enExample) |
| CA (1) | CA3067351A1 (enExample) |
| IL (1) | IL271398A (enExample) |
| WO (1) | WO2018232188A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6815196B2 (ja) | 2013-03-13 | 2021-01-20 | イマジナブ、 インコーポレイテッド | Ｃｄ８に対する抗原結合性構築物 |
| KR20250008141A (ko) | 2015-08-07 | 2025-01-14 | 이미지냅 인코포레이티드 | 분자를 표적화하기 위한 항원 결합 구조체 |
| EP3638299A4 (en) * | 2017-06-15 | 2021-03-31 | Memorial Sloan-Kettering Cancer Center | ANTI-L1-CAM ANTIBODIES AND THEIR USES |
| CN119930818A (zh) | 2018-06-29 | 2025-05-06 | 爱必泰生物有限公司 | 抗l1cam抗体及其用途 |
| KR20210152472A (ko) * | 2019-03-11 | 2021-12-15 | 메모리얼 슬로안 케터링 캔서 센터 | Cd22 항체 및 이를 사용하는 방법 |
| KR20220006065A (ko) * | 2019-04-08 | 2022-01-14 | 메모리얼 슬로안 케터링 캔서 센터 | Cd19 항체 및 이의 사용 방법 |
| EP4150338A1 (en) * | 2020-05-15 | 2023-03-22 | Alexion Pharmaceuticals, Inc. | Method of using extracellular vesicles to detect complement activation, and uses thereof to assess and/or monitor treatment of a complement-mediated disease |
| CN114558122B (zh) * | 2022-04-27 | 2023-02-21 | 北京肿瘤医院(北京大学肿瘤医院) | 放射核素标记的过氧化氢酶及其应用 |
| TW202421652A (zh) * | 2022-09-21 | 2024-06-01 | 瑞士商艾爾瑟拉股份有限公司 | 結合至l1cam之新穎結合分子 |
| AU2023376983A1 (en) | 2022-11-09 | 2025-04-17 | Cis Biopharma Ag | Anti-l1-cam antibodies and their uses for diagnostic and therapeutic applications |
| WO2025238187A1 (en) | 2024-05-15 | 2025-11-20 | Cis Biopharma Ag | Immunoconjugates targeting l1-cam |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107045A (en) * | 1994-06-30 | 2000-08-22 | Oklahoma Medical Research Foundation | Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| US6972323B1 (en) * | 1997-04-01 | 2005-12-06 | Sankyo Company, Limited | Anti-Fas antibodies |
| WO2007114550A1 (en) * | 2006-04-03 | 2007-10-11 | Korea Research Institute Of Bioscience And Biotechnology | A novel monoclonal antibody specific to the l1cam, a hybridoma producing the same and a method producing the same |
| JP4560582B2 (ja) * | 2006-06-02 | 2010-10-13 | アベオ ファーマシューティカルズ， インコーポレイテッド | 肝細胞成長因子（ｈｇｆ）結合蛋白質 |
| CN101605560B (zh) * | 2006-08-23 | 2013-06-26 | 韩国生命工学研究院 | 治疗胆管癌的药物组合物 |
| AU2008201871A1 (en) * | 2008-04-16 | 2009-11-26 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Inhibition of angiogenesis and tumor metastasis |
| KR101501736B1 (ko) * | 2008-12-05 | 2015-03-12 | 한국생명공학연구원 | 인간 및 마우스에서 발현하는 ｌ1ｃａｍ에 특이적으로 결합하는 재조합 단일클론항체 및 그 이용 |
| WO2011063523A1 (en) * | 2009-11-24 | 2011-06-03 | Alethia Biotherapeutics Inc. | Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| SG190362A1 (en) | 2010-11-24 | 2013-06-28 | Glaxo Group Ltd | Multispecific antigen binding proteins targeting hgf |
| ES2692268T5 (en) | 2011-03-29 | 2025-02-26 | Roche Glycart Ag | Antibody fc variants |
| AU2012356894B2 (en) * | 2011-12-23 | 2018-01-18 | Araris Biotech Ltd. | Enzymatic conjugation of polypeptides |
| CN104936984B (zh) * | 2012-11-16 | 2018-09-14 | 江原大学校产学协力团 | 特异性结合人和小鼠l1cam的抗体及其用途 |
| CA2926215A1 (en) * | 2013-10-06 | 2015-04-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modified pseudomonas exotoxin a |
| EP3638299A4 (en) * | 2017-06-15 | 2021-03-31 | Memorial Sloan-Kettering Cancer Center | ANTI-L1-CAM ANTIBODIES AND THEIR USES |
-
2018
- 2018-06-14 EP EP18818419.6A patent/EP3638299A4/en active Pending
- 2018-06-14 WO PCT/US2018/037645 patent/WO2018232188A1/en not_active Ceased
- 2018-06-14 JP JP2019569397A patent/JP7353187B2/ja active Active
- 2018-06-14 US US16/622,274 patent/US11597764B2/en active Active
- 2018-06-14 CN CN202411020658.9A patent/CN119161477A/zh active Pending
- 2018-06-14 CA CA3067351A patent/CA3067351A1/en active Pending
- 2018-06-14 CN CN201880052266.7A patent/CN111093693B/zh active Active
-
2019
- 2019-12-12 IL IL271398A patent/IL271398A/en unknown
-
2023
- 2023-03-06 US US18/179,159 patent/US12486323B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wei et al. | Current landscape and future directions of bispecific antibodies in cancer immunotherapy | |
| Goebeler et al. | Bispecific and multispecific antibodies in oncology: opportunities and challenges | |
| Paul et al. | Cancer therapy with antibodies | |
| Barzaman et al. | Breast cancer immunotherapy: Current and novel approaches | |
| JP2022546572A5 (enExample) | ||
| IL273484B1 (en) | A33 antibody compositions and methods of using the same in radioimmunotherapy | |
| JP2021531764A5 (enExample) | ||
| JP2023523584A5 (enExample) | ||
| JP2020534017A5 (enExample) | ||
| JP2020103301A5 (enExample) | ||
| Chandramohan et al. | Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy | |
| Lutterbuese et al. | Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA | |
| JP2020534250A5 (enExample) | ||
| JP2022538117A5 (enExample) | ||
| JP2023537002A5 (enExample) | ||
| FI3802608T3 (fi) | Cd3-vasta-aineita ja niiden käyttötapoja | |
| JP2020501531A5 (enExample) | ||
| JP2021517816A5 (enExample) | ||
| JP2021520208A5 (enExample) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| JP2020507571A5 (enExample) | ||
| JP2020512281A5 (enExample) | ||
| JP2015529641A5 (enExample) | ||
| US20240197931A1 (en) | Radioimmunotherapy directed to ccr8 for depletion of tumor infiltrating regulatory t cells | |
| JP2022511471A5 (enExample) |